| Healthlinc - Corporate | |
|
2401 Valley Dr Valparaiso IN 46383-2520 | |
| (219) 413-5100 | |
| Not Available |
| Full Name | Healthlinc - Corporate |
|---|---|
| Speciality | Clinic/Center |
| Location | 2401 Valley Dr, Valparaiso, Indiana |
| Authorized Official Name and Position | Melissa Mitchell (CEO) |
| Authorized Official Contact | 2194659503 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Healthlinc - Corporate 2401 Valley Dr Valparaiso IN 46383-2520 Ph: (219) 413-5100 | Healthlinc - Corporate 2401 Valley Dr Valparaiso IN 46383-2520 Ph: (219) 413-5100 |
| NPI Number | 1578293452 |
|---|---|
| Provider Enumeration Date | 06/14/2022 |
| Last Update Date | 01/12/2024 |
| Medicare PECOS PAC ID | 7618929373 |
|---|---|
| Medicare Enrollment ID | O20220624001331 |
News Archive
Based on promising data from initial clinical trials in late 2014, WHO with the Health Ministry of Guinea, Médecins Sans Frontières, Epicentre and The Norwegian Institute of Public Health, will launch a Phase III trial in Guinea on 7 March to test the VSV-EBOV vaccine for efficacy and effectiveness to prevent Ebola.
Super Bowl XLVIII is only a couple of days away and many families across the country are gearing up for game day celebrations. Because TVs will be such a large part of the festivities this weekend, the doctors in the Comprehensive Children's Injury Center at Cincinnati Children's Hospital Medical Center wanted to discuss the injury risks associated with TVs and share some steps that adults can take to keep kids safe this weekend and throughout the year.
Researchers at the University Hospital of Magdeburg (Germany) have discovered that atrial tachycardia is associated with mitochondrial dysfunction and oxidative stress followed by the activation of the NF-kB signalling pathway with induction of NF-kB target gene expression in atrial tissue.
Scientists investigating the genetic causes and altered functioning of nerve cells in motor neurone disease (MND) have discovered a new mechanism that could lead to fresh treatment approaches for one of the most common forms of the disease.
McKesson Corporation today reaffirmed its earnings guidance for the fiscal year ending March 31, 2011 and the underlying key assumptions provided in its press release of May 3, 2010. As previously stated, McKesson expects to earn between $4.72 and $4.92 per diluted share for the fiscal year ending March 31, 2011.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578293452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Secondary |
News Archive
Based on promising data from initial clinical trials in late 2014, WHO with the Health Ministry of Guinea, Médecins Sans Frontières, Epicentre and The Norwegian Institute of Public Health, will launch a Phase III trial in Guinea on 7 March to test the VSV-EBOV vaccine for efficacy and effectiveness to prevent Ebola.
Super Bowl XLVIII is only a couple of days away and many families across the country are gearing up for game day celebrations. Because TVs will be such a large part of the festivities this weekend, the doctors in the Comprehensive Children's Injury Center at Cincinnati Children's Hospital Medical Center wanted to discuss the injury risks associated with TVs and share some steps that adults can take to keep kids safe this weekend and throughout the year.
Researchers at the University Hospital of Magdeburg (Germany) have discovered that atrial tachycardia is associated with mitochondrial dysfunction and oxidative stress followed by the activation of the NF-kB signalling pathway with induction of NF-kB target gene expression in atrial tissue.
Scientists investigating the genetic causes and altered functioning of nerve cells in motor neurone disease (MND) have discovered a new mechanism that could lead to fresh treatment approaches for one of the most common forms of the disease.
McKesson Corporation today reaffirmed its earnings guidance for the fiscal year ending March 31, 2011 and the underlying key assumptions provided in its press release of May 3, 2010. As previously stated, McKesson expects to earn between $4.72 and $4.92 per diluted share for the fiscal year ending March 31, 2011.
› Verified 4 days ago
Healthlinc - Porter-starke Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 701 Wall St, Valparaiso, IN 46383 Phone: 219-299-8419 Fax: 219-462-7504 | |
Indiana Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 407 E Lincolnway, Valparaiso, IN 46383 Phone: 888-339-7339 | |
New Beginnings Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 109 Fordwick Ln, Valparaiso, IN 46383 Phone: 219-671-1881 | |
B Waldo Md Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3000 Pepper Creek Bridge Pkwy, Valparaiso, IN 46385 Phone: 773-520-1950 | |
Sudhakar Garlapati Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 401 Wall St, Valparaiso, IN 46383 Phone: 219-462-2106 | |
Michigan City In Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2206 Roosevelt Rd, Ste A, Valparaiso, IN 46383 Phone: 219-464-9507 Fax: 219-477-4690 | |
James E. Taylor Medical Professional Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2102 Evans Ave, Suite 111, Valparaiso, IN 46383 Phone: 219-464-9521 |